Skip to main content
BioCentury, the Bernstein Report on BioBusiness
As published for the week of Monday, September 29, 2014

  • Cover Story: Politics, Policy & Law: Patching compassionate access

    Congress might move on compassionate access; wholesale reform looks unlikely

    By Steve Usdin, Washington Editor

    Six months after a viral media campaign saved seven-year-old Josh Hardy's life by persuading Chimerix Inc. to work with FDA to provide access to an investigational therapy, new compassionate access policies are being debated in the halls of Congress, corporate boardrooms and academic think tanks. So far, the legislative provisions under consideration represent only incremental changes to the system.

    While cable television and Twitter have long since moved on, last week Rep. Michael McCaul (R-Texas), co-chair of the congressional childhood cancer caucus, told BioCentury he is drafting compassionate access legislation that he plans to introduce in 2015.

    Full Article

Money Raised in 2014

Last week, the biotech industry raised $588 million, bringing to $40 billion the total raised year-to-date. In 2013, a total of $37.2 billion was raised, including $14.4 billion in debt, $10 billion in follow-ons, $2.8 billion in PIPEs and other equity, $3.9 billion in IPOs, and $6 billion in venture capital. Totals include overallotments and warrants, and are rounded to the nearest millions.

Subscribe Now
Free Trial

Preclinical Results